Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies

Humans possess abundant amounts of microorganisms, including bacteria, fungi, viruses, and archaea, in their gut. Patients with nonalcoholic fatty liver disease (NAFLD) exhibit alterations in their gut microbiome and an impaired gut barrier function. Preclinical studies emphasize the significance of...

Descripción completa

Detalles Bibliográficos
Autores principales: Koning, Mijra, Herrema, Hilde, Nieuwdorp, Max, Meijnikman, Abraham S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305510/
https://www.ncbi.nlm.nih.gov/pubmed/37610978
http://dx.doi.org/10.1080/19490976.2023.2226922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305510/
https://www.ncbi.nlm.nih.gov/pubmed/37610978
http://dx.doi.org/10.1080/19490976.2023.2226922

Ejemplares similares